Top
Contact Us

Care is just a click away. 
Contact us to learn more:

This form does not yet contain any fields.
    « GeneKey at forefront of personal tumor profiling companies | Main | GeneKey Announces Launch »
    Friday
    Dec312010

    Enlisting the Dying for Clues to Save Others

    DateFriday, December 31, 2010 at 12:21PM

    This New York Times story about research to identify treatments for melanoma patients who have developed resistance to PLX4032 is extremely relevant. GeneKey provides genomic analysis to identify potential therapies for patients who find themselves in a similar situation.

    AuthorAdmin | CommentPost a Comment |

    Reader Comments

    There are no comments for this journal entry. To create a new comment, use the form below.

    PostPost a New Comment

    Enter your information below to add a new comment.

    My response is on my own website »
    Author Email (optional):
    Author URL (optional):
    Post:
     
    Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>
    Alert
    Comment Moderation Enabled
    Your comment will not appear until it has been cleared by a website editor.

    Notify me of follow-up comments via email.